EFFICACY OF 12-WEEK PEGCETACOPLAN IN KIDNEY TRANSPLANT RECIPIENTS WITH RECURRENT C3 GLOMERULOPATHY (C3G) OR IMMUNE COMPLEX MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS (IC-MPGN)

Back

E-Poster

https://storage.unitedwebnetwork.com/files/1099/3e3d1d65009e68f679606c1cb66c7c49.pdf

Abstract Title

First Name *

Lucia

Last Name *

Quintana-Gallardo

Co-author 1

Andrew Bomback asb68@cumc.columbia.edu Columbia University, Irving Medical Center NA New York

Co-author 2

Erica Daina erica.daina@marionegri.it Istituto di Ricerche Farmacologiche Mario Negri, IRCCS NA Bergamo

Co-author 3

John Kanellis john.kanellis@monash.edu Monash Medical Centre NA Clayton

Co-author 4

David Kavanagh david.kavanagh@newcastle.ac.uk National Renal Complement Therapeutics Centre, Newcastle University NA Newcastle

Co-author 5

Matthew C. Pickering matthew.pickering@imperial.ac.uk Imperial College NA London

Co-author 6

Gere Sunder-Plassmann gere.sunder-plassmann@meduniwien.ac.at Medical University of Vienna NA Vienna

Co-author 7

Patrick Walker patrick.walker@arkanalabs.com Arkana Laboratories NA Little Rock

Co-author 8

Zhongshen Wang zhongshen.wang@apellis.com Apellis Pharmaceuticals, Inc NA Waltham

Co-author 9

Zurish Ahmad zurish.ahmad@apellis.com Apellis Pharmaceuticals, Inc NA Waltham

Co-author 10

Fadi Fakhouri fadi.fakhouri@unil.ch Lausanne University Hospital, Centre Hospitalier Universitaire Vaudois NA Lausanne

Co-author 11

Co-author 12

Co-author 13

Co-author 14

Co-author 15